Enabling Scalable & Cost-Effective Point of Care for Cell & Gene Therapies

Presented by

Qasim Rafiq, Xavier de Mollerat du Jeu, Sean Chang

About this talk

The transformative potential to change the way human disease is treated using cell and gene therapy has motivated rapid technological advancements towards streamlining manufacturing processes. Standardization via automation and introduction of quality control via closed system manufacturing will contribute to overcoming barriers and facilitate the reach of this treatment to broader patient populations. In this webinar, Decentralized Manufacturing: Enabling Scalable and Cost-Effective Point of Care for Cell and Gene Therapies, industry leaders from the University College London and Thermo Fisher Scientific discuss the evolution of the industry and where it's headed. You'll learn about drivers and challenges associated with decentralized manufacturing, how streamlined processes can enable scalable point of care, and closed, modular, automated cell therapy workflow solutions.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (5)
Subscribers (233)
Thermo Fisher Scientific connects you with the technical expertise, regulatory guidance, and custom or off-the-shelf solutions you need to overcome obstacles, streamline processes and advance your cell and gene therapies.